These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24816950)

  • 21. Oncologic outcome of hypopharyngeal carcinoma treated with different modalities at 2 different university hospitals.
    Bussu F; Mura F; Miccichè F; Bertino G; Occhini A; Almadori G; Galli J; Pandolfini M; Gallus R; Autorino R; Guidi ML; Dinapoli N; Valentini V; Paludetti G; Benazzo M
    Head Neck; 2016 Apr; 38(4):606-12. PubMed ID: 25491424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Roberts DB; Lewin JS; Lai SY
    Head Neck; 2013 Nov; 35(11):1641-6. PubMed ID: 23322545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of the results of chemoradiotherapy and surgical treatment for hypopharyngeal cancer.
    Demirci U; Özmen ÖA; Demiröz C; Kasapoğlu F; Coşkun HH; Özkan L; Onart S
    Kulak Burun Bogaz Ihtis Derg; 2013; 23(5):275-81. PubMed ID: 24010801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.
    Rodriguez CP; Adelstein DJ; Rybicki LA; Savvides P; Saxton JP; Koyfman SA; Greskovich JF; Yao M; Scharpf J; Lavertu P; Wood BG; Burkey BB; Lorenz RR; Rezaee RP; Zender CA; Ives DI
    Head Neck; 2015 Nov; 37(11):1583-9. PubMed ID: 24909549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL; Yuan KS; Wu SY
    Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
    Seiwert TY; Melotek JM; Blair EA; Stenson KM; Salama JK; Witt ME; Brisson RJ; Chawla A; Dekker A; Lingen MW; Kocherginsky M; Villaflor VM; Cohen EE; Haraf DJ; Vokes EE
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):21-9. PubMed ID: 27511844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer.
    Dragovic AF; Bonner JA; Spencer SA; Nabell LM; Carroll WR; Caudell JJ
    Head Neck; 2011 Nov; 33(11):1551-6. PubMed ID: 21990218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer.
    Chitapanarux I; Tharavichitkul E; Kamnerdsupaphon P; Pukanhapan N; Vongtama R
    J Radiat Res; 2013 Nov; 54(6):1110-7. PubMed ID: 23740894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with locally advanced hypopharyngeal carcinoma. Results over a 30-year period.
    León X; López M; García J; Rovira C; Casasayas M; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(6):315-326. PubMed ID: 30527320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of surgical margin status on the outcomes of locally advanced hypopharyngeal squamous cell carcinoma treated by primary surgery.
    Li M; Xie M; Zhou L; Wang S
    Acta Otolaryngol; 2018 Dec; 138(12):1136-1145. PubMed ID: 30691335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
    Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
    Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
    Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy.
    Platek ME; Reid ME; Wilding GE; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Warren GW; Sullivan M; Thorstad WL; Khan MK; Loree TR; Singh AK
    Head Neck; 2011 Nov; 33(11):1561-8. PubMed ID: 21990220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
    Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
    Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
    Tsai YT; Chen WC; Chien CY; Hsu CM; Lee YC; Tsai MS; Lin MH; Lai CH; Chang KP
    World J Surg Oncol; 2020 May; 18(1):82. PubMed ID: 32357934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of upfront neck dissection in definitive radiotherapy for locally advanced hypopharyngeal squamous cell carcinoma: A single-center retrospective analysis.
    Katano A; Yamashita H; Saito Y; Kobayashi K
    Head Neck; 2024 Nov; 46(11):2815-2823. PubMed ID: 38842032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.
    Lim SH; Lee SJ; Ahn MJ; Park K; Sun JM
    Jpn J Clin Oncol; 2016 Jan; 46(1):40-5. PubMed ID: 26561556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.